Vaccines,
Journal Year:
2022,
Volume and Issue:
10(7), P. 1003 - 1003
Published: June 23, 2022
Since
its
first
description
in
November
2021,
the
SARS-CoV-2
variant
of
concern
Omicron
(B.1.1.529)
has
emerged
as
dominant
strain
COVID-19
pandemic.
To
date,
it
remains
unclear
if
boosted
vaccination
protects
against
transmission.
Using
data
from
largest
German
Public
Health
Department,
Cologne,
we
analyzed
breakthrough
infections
booster-vaccinated
infected
persons
(IP;
group
(BVG);
n
=
202)
and
fully
vaccinated,
not
SARS-COV2-positive
patients
(>3
month
after
receiving
second
dose;
unboosted,
vaccinated
(FVG);
to
close
contacts
compared
an
age-
sex-matched
unvaccinated
control
(UCG;
202).
On
average,
IPs
had
0.42
±
0.52
relation
total
number
BVG
vs.
0.57
0.44
FVG
0.56
0.43
UVG
(p
0.054).
In
median
test,
pairwise
comparison
revealed
a
significant
difference
between
both
other
groups;
no
was
found
group.
Now,
these
findings
must
be
verified
larger
samples,
considering
role
subvariants
status
contact
person.
However,
importance
booster
breaking
possible
chains
infection
immune
escape
is
obvious.
Applied Sciences,
Journal Year:
2022,
Volume and Issue:
12(16), P. 8029 - 8029
Published: Aug. 11, 2022
The
COVID-19
disease
has
spread
worldwide
since
2020,
causing
a
high
number
of
deaths
as
well
infections,
and
impacting
economic,
social
health
systems.
Understanding
its
dynamics
may
facilitate
better
understanding
behavior,
reducing
the
impact
similar
diseases
in
future.
Classical
modeling
techniques
have
failed
predicting
behavior
this
disease,
they
been
unable
to
capture
hidden
features
data
collected
about
disease.
present
research
benefits
from
capacity
modern
computers
new
trends
artificial
intelligence
(AI),
specifically
three
deep
learning
(DL)
neural
networks:
recurrent
network
(RNN),
gated
unit
(GRU),
long
short-term
memory
(LSTM).
We
thus
modelled
daily
infections
four
countries
(Saudi
Arabia,
Egypt,
Italy,
India)
that
vary
their
climates,
cultures,
populations,
results
show
simple-structure
RNN
algorithm
is
at
DL
promising
potential
can
be
used
efficiently
even
case
limited
datasets.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(2), P. 1553 - 1553
Published: Jan. 13, 2023
The
SARS-CoV-2
pandemic
has
demonstrated
the
need
to
create
highly
effective
antivirals
and
vaccines
against
various
RNA
viruses,
including
SARS
coronaviruses.
This
paper
provides
a
short
review
of
innovative
strategies
in
development
coronaviruses,
with
focus
on
antisense
antivirals,
oligonucleotide
adjuvants
vaccines,
vaccines.
Well-developed
viral
genomic
databases
new
opportunities
for
using
post-genomic
platform.
most
coronaviruses
are
those
able
form
memory
cells
both
humoral
cellular
immunity.
efficiently
stop
replication
without
side
effects.
Oligonucleotide
can
resist
rapidly
changing
sequences
conserved
regions
their
genomes
generate
long-term
immune
response.
Oligonucleotides
have
been
used
as
excellent
decades,
increasing
data
show
that
oligonucleotides
could
serve
antigens
vaccine
formulations,
becoming
prospective
tool
system
tuning.
Pathogens,
Journal Year:
2022,
Volume and Issue:
11(6), P. 646 - 646
Published: June 3, 2022
While
disease
control
in
racing
pigeons
and
the
potential
role
of
as
vectors
transmitting
viruses
to
poultry
are
importance,
there
is
still
a
paucity
data
concerning
occurrence
coronaviruses
pigeons.
In
this
study,
215
domestic
were
tested
for
presence
coronaviral
genetic
material
using
nested
PCR
method,
which
revealed
57
positive
samples
(26.51%).
The
difference
coronavirus
prevalence
between
young
adult
(34.34%
19.83%,
respectively)
has
been
found
statistically
significant.
contrast,
no
significant
demonstrated
symptomatic
asymptomatic
birds,
leaving
influence
on
pigeon
health
uncertain.
Phylogenetic
analysis
RdRp
gene
fragment
allowed
us
assign
all
obtained
strains
Gammacoronavirus
genus
Igacovirus
subgenus.
phylogenetic
tree
plotted
ML
method
that
those
sequences
formed
group
most
similar
from
China,
Finland,
Poland,
single
strain
common
starling
suggests
wide
geographical
distribution
virus
its
possible
transmission
various
species.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(10), P. 8573 - 8573
Published: May 10, 2023
Millions
of
SARS-CoV-2
whole
genome
sequences
have
been
generated
to
date.
However,
good
quality
data
and
adequate
surveillance
systems
are
required
contribute
meaningful
in
public
health.
In
this
context,
the
network
Spanish
laboratories
for
coronavirus
(RELECOV)
was
created
with
main
goal
promoting
actions
speed
up
detection,
analyses,
evaluation
at
a
national
level,
partially
structured
financed
by
an
ECDC-HERA-Incubator
action
(ECDC/GRANT/2021/024).
A
sequencing
control
assessment
(QCA)
developed
evaluate
network's
technical
capacity.
QCA
full
panel
results
showed
lower
hit
rate
lineage
assignment
compared
that
obtained
variants.
Genomic
comprising
48,578
viral
genomes
were
studied
evaluated
monitor
SARS-CoV-2.
The
36%
increase
sharing
sequences.
addition,
analysis
lineage/sublineage-defining
mutations
track
virus
characteristic
mutation
profiles
Delta
Omicron
Further,
phylogenetic
analyses
strongly
correlated
different
variant
clusters,
obtaining
robust
reference
tree.
RELECOV
has
made
it
possible
improve
enhance
genomic
Spain.
It
provided
tools
monitoring
characterization
make
knowledge
efficiently
quickly,
Vaccines,
Journal Year:
2022,
Volume and Issue:
10(7), P. 1003 - 1003
Published: June 23, 2022
Since
its
first
description
in
November
2021,
the
SARS-CoV-2
variant
of
concern
Omicron
(B.1.1.529)
has
emerged
as
dominant
strain
COVID-19
pandemic.
To
date,
it
remains
unclear
if
boosted
vaccination
protects
against
transmission.
Using
data
from
largest
German
Public
Health
Department,
Cologne,
we
analyzed
breakthrough
infections
booster-vaccinated
infected
persons
(IP;
group
(BVG);
n
=
202)
and
fully
vaccinated,
not
SARS-COV2-positive
patients
(>3
month
after
receiving
second
dose;
unboosted,
vaccinated
(FVG);
to
close
contacts
compared
an
age-
sex-matched
unvaccinated
control
(UCG;
202).
On
average,
IPs
had
0.42
±
0.52
relation
total
number
BVG
vs.
0.57
0.44
FVG
0.56
0.43
UVG
(p
0.054).
In
median
test,
pairwise
comparison
revealed
a
significant
difference
between
both
other
groups;
no
was
found
group.
Now,
these
findings
must
be
verified
larger
samples,
considering
role
subvariants
status
contact
person.
However,
importance
booster
breaking
possible
chains
infection
immune
escape
is
obvious.